Efficacy and Safety of Piperacillin-Tazobactam: Systematic Review and Metaanalysis

Authors: Bes David , Sberna Norma , Herrera Ramos Estefanía and Lede Roberto

Volume 5, Issue 1

Abstract

Introduction: Piperacillin-tazobactam (PTZ), although contested, is frequently utilized for empirical treatment of Gram-negative bacteria treatment. Objective: Systematic review to evaluate if PTZ is associated with lower rates of treatment failure and fewer adverse effects than other comparators. Material and Methods: Literature search in Embase, and MEDLINE databases using acepiperacillin tazobactamae as a leading term. A study qualified, when a properly randomized control trial (RCT) compared the efficacy and safety of PTZ with other antibacterial agents in an aeœintention to treat analysis of clinically evaluable patients. Results: Eleven studies fulfilled the inclusion criteria. Pooled RR of failure risk rate was 25% less using PTZ than other comparators (0.75; CI 95% 0.59-0.95). Adverse effects were similar. Conclusions: PTZ can be adequately considered for empirical treatment of patients with Gram-negative bacteria infections

Keywords: Piperacillin-Tazobactan; Efficacy; Bacterial Infections; Safety; Gram Negative; Empiric Therapy; Systematic Review; Failure

View PDF